Shares of Glenmark Life Sciences, the leading developer and manufacturer of select high-value pharmaceuticals, will be listed on the BSE and NSE on Friday, August 6. Glenmark Life Sciences Initial Public Offer is currently commanding a premium of around 13 percent in the grey market ahead of listing. Glenmark Life Sciences IPO GMP is Rs 85. Glenmark Life Sciences shares will be listed on the Bombay Stock Exchange and National Stock Exchange at 10 am.
According to market observers, investors could get around 15 to 20 percent listing gain. Glenmark Life Sciences is a wholly-owned subsidiary of Glenmark Pharmaceuticals. Glenmark Life Sciences IPO had received bids of over 66.33 crore (66,33,24,160) shares against the total issue size of over 1.50 crore (1,50,18,279) shares. The price band was fixed at Rs 695-720 per share. The allotment was done at Rs 720 per share.
Adani Transmission posts 22 percent rise in June qtr, Stock Rise today
Relief for Gautam Adani, Modi govt given 90 days for this work
